TrialBone marrow transplantation2013

Second hematopoietic SCT for leukemia relapsing after myeloablative T cell-depleted transplants does not prolong survival.

Z A McIver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.